Maria Ercilia Ibarra, Sebastián Altuna, Martín Mariano Ballarin, M. Betti, C. Maya, Tomás Demarco, J. Balparda
{"title":"子宫转位:是局部晚期宫颈癌保留生育能力的一种选择吗","authors":"Maria Ercilia Ibarra, Sebastián Altuna, Martín Mariano Ballarin, M. Betti, C. Maya, Tomás Demarco, J. Balparda","doi":"10.1136/ijgc-2022-esgo.390","DOIUrl":null,"url":null,"abstract":"factors for recurrence. 35 patients were treated with a recurrence of a BOT. FSS was repeated in 11 (36.7%) patients. After FSS, the recurrence rate was 1/11 (9%). After complete surgical staging,","PeriodicalId":292924,"journal":{"name":"Fertility/Pregnancy","volume":"47 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"2022-RA-1545-ESGO Uterine transposition: is it an option for fertility sparing in locally advanced cervical cancer\",\"authors\":\"Maria Ercilia Ibarra, Sebastián Altuna, Martín Mariano Ballarin, M. Betti, C. Maya, Tomás Demarco, J. Balparda\",\"doi\":\"10.1136/ijgc-2022-esgo.390\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"factors for recurrence. 35 patients were treated with a recurrence of a BOT. FSS was repeated in 11 (36.7%) patients. After FSS, the recurrence rate was 1/11 (9%). After complete surgical staging,\",\"PeriodicalId\":292924,\"journal\":{\"name\":\"Fertility/Pregnancy\",\"volume\":\"47 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fertility/Pregnancy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ijgc-2022-esgo.390\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fertility/Pregnancy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ijgc-2022-esgo.390","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
2022-RA-1545-ESGO Uterine transposition: is it an option for fertility sparing in locally advanced cervical cancer
factors for recurrence. 35 patients were treated with a recurrence of a BOT. FSS was repeated in 11 (36.7%) patients. After FSS, the recurrence rate was 1/11 (9%). After complete surgical staging,
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
